U.S. Online Retail and Ecommerce Stock News

NYSE:EVTL
NYSE:EVTLAerospace & Defense

Vertical Aerospace (EVTL) Valuation Check As Valo U.S. Tour Highlights Urban Air Mobility Progress

Vertical Aerospace (EVTL) has drawn fresh attention after bringing its Valo electric aircraft to New York City. The company has started a U.S. tour that showcases planned urban air routes with Bristow Group and Skyports Infrastructure. See our latest analysis for Vertical Aerospace. Those Valo tour headlines come after a mixed stretch for the stock, with a 28.74% 90 day share price return, a 3.95% year to date share price decline, and a 72.82% three year total shareholder return loss that...
NasdaqCM:VELO
NasdaqCM:VELOMachinery

Assessing Velo3D (VELO) Valuation After New U.S. Army DEVCOM GVSC Supply Chain Agreement

Velo3D (VELO) stock is in focus after the company signed a Cooperative Research & Development Agreement with the U.S. Army DEVCOM GVSC to develop additively manufactured parts for ground combat vehicles. See our latest analysis for Velo3D. The agreement with the U.S. Army arrives after a sharp reset in sentiment, with a 1-day share price return of -16.76% and a 7-day share price return of -30.39% following a very large 90-day gain of 159.04%. However, the 1-year total shareholder return of...
NYSE:FET
NYSE:FETEnergy Services

A Look At Forum Energy Technologies (FET) Valuation As Offshore And Subsea Sentiment Drives Fresh Volatility

Forum Energy Technologies (FET) is back on many investors’ screens as offshore and subsea spending plans, project pipelines, and pricing discipline come under fresh scrutiny, adding volatility to trading in smaller energy technology names. See our latest analysis for Forum Energy Technologies. At a share price of $43.62, Forum Energy Technologies has seen short term momentum build, with a 30 day share price return of 18.69% and a 90 day share price return of 38.04%. The 1 year total...
NYSE:GRDN
NYSE:GRDNHealthcare

Guardian Pharmacy Services’ (GRDN) Flat 2026 Revenue Guide: Pragmatic Planning or Fading Growth Ambition?

In January 2026, Guardian Pharmacy Services, Inc. reaffirmed its 2025 revenue guidance of US$1.43 billion to US$1.45 billion and issued new 2026 guidance of US$1.40 billion to US$1.42 billion. This updated outlook gives investors a clearer view of expected near-term revenue trends and reflects management’s willingness to quantify its forward plans. Next, we’ll examine how the reaffirmed 2025 outlook and newly issued 2026 revenue range shape Guardian Pharmacy Services’ investment...
NasdaqGM:BGL
NasdaqGM:BGLMetals and Mining

Blue Gold (BGL) Is Up 71.4% After Gold Prices Hit Record Highs Amid Geopolitical Tensions – Has The Bull Case Changed?

Blue Gold Ltd recently benefited as gold and other precious metals climbed to record highs amid geopolitical tensions, economic uncertainty and expectations of Federal Reserve rate cuts. This surge in demand for gold highlights how macroeconomic and currency conditions can quickly shift investor attention toward producers like Blue Gold. We will now examine how heightened demand for gold, driven by geopolitical and economic uncertainty, influences Blue Gold’s broader investment...
NYSE:RPM
NYSE:RPMChemicals

How Investors May Respond To RPM (RPM) Cost Savings Plan Amid Earnings Pressures And Insider Selling

RPM International recently announced about US$100 million in expected annual SG&A savings and guided to mid-single-digit sales growth with mid- to high-single-digit adjusted EBIT growth for fiscal Q3 and Q4 2026, while JPMorgan upgraded the stock and Vice President of Operations Timothy R. Kinser sold 3,441 shares on January 21, 2026. An interesting angle for investors is how RPM’s cost-optimization push and upgraded analyst view are emerging despite recent operational and earnings...
NasdaqGS:SLAB
NasdaqGS:SLABSemiconductor

New Cold Chain IoT Beacon Partnership and Analyst Coverage Might Change The Case For Investing In Silicon Laboratories (SLAB)

Silicon Labs recently drew market attention as RBC Capital initiated coverage and the company expanded its Internet of Things footprint through a new collaboration with MOKOSMART on high-precision Bluetooth beacons for global cold chain visibility. This combination of fresh analyst focus and a targeted cold chain solution underscores Silicon Labs’ role as a provider of specialized, low-power wireless infrastructure across connected devices. Next, we’ll examine how this new cold chain...
NasdaqGS:SLDP
NasdaqGS:SLDPAuto Components

What Solid Power (SLDP)'s Rising Short Interest Means For Shareholders

Recently, Solid Power Inc. reported that short interest rose 4.7%, leaving 12.93% of its available float sold short, above peer averages. This elevated level of bearish positioning makes Solid Power one of the more heavily shorted names in its group, sharpening focus on sentiment risks. Next, we’ll examine how this heightened short interest shapes Solid Power’s investment narrative and what it might signal about investor conviction. We've found 13 US stocks that are forecast to pay a...
NasdaqGS:WABC
NasdaqGS:WABCBanks

Weaker Earnings And New Director Appointment Could Be A Game Changer For Westamerica Bancorporation (WABC)

Westamerica Bancorporation recently reported fourth-quarter and full-year 2025 results showing year-over-year declines in net interest income, net income, and earnings per share, while also declaring a quarterly cash dividend of US$0.46 per share payable on February 13, 2026. In addition, the board appointed marketing and business strategy veteran Carter Welch as an independent director effective February 26, 2026, signaling a potential shift in how the bank thinks about growth and client...
NasdaqGM:CHRS
NasdaqGM:CHRSBiotechs

Coherus Oncology (CHRS) Taps ATM Facility: Strategic Lifeline or Dilution Trade-Off for Its Pipeline?

Coherus Oncology, Inc. recently filed a prospectus supplement allowing it to sell up to US$64.88 million of common stock through an at-the-market offering, shortly after Oppenheimer began covering the company with an Outperform rating based on its oncology pipeline. The focus on the anti-CCR8 antibody tagmokitug and the PD-1 inhibitor Loqtorzi highlights how investors are weighing pipeline potential against ongoing capital needs. We’ll now examine how this combination of fresh equity...
NYSE:NSC
NYSE:NSCTransportation

The Bull Case For Norfolk Southern (NSC) Could Change Following New Chicago–New England Double-Stack Corridor Launch

Norfolk Southern has launched its East Edge double-stack intermodal corridor connecting Chicago and New England, replacing an older single-stack route with a faster, higher-capacity line backed by extensive track, bridge, tunnel, and signal upgrades completed with multiple public and private partners. A single 9,000-foot double-stack train on this corridor can theoretically support up to 200,000 loads a year through Ayer, Massachusetts, vastly expanding New England’s primary intermodal hub...